• Home
  • Customers
    • Primary Care
    • Secondary Care
    • Suppliers
  • Products
    • MedSourcing Hub
    • MedSupply Intelligence
  • Blog
  • About Us
  • Contact
  • More
    • Home
    • Customers
      • Primary Care
      • Secondary Care
      • Suppliers
    • Products
      • MedSourcing Hub
      • MedSupply Intelligence
    • Blog
    • About Us
    • Contact
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Customers
    • Primary Care
    • Secondary Care
    • Suppliers
  • Products
    • MedSourcing Hub
    • MedSupply Intelligence
  • Blog
  • About Us
  • Contact

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

The shortage of prescription drugs drives up costs, leaves consumers vulnerable to price gouging and threatens our health and safety


Barack Obama 2011

Check out some of our latest insights

EU Parliament Regulation To Tackle Critical Medicine Shortages

27 Drug Makers Sign Deal to Manufacture Generic of Molnupiravir

27 Drug Makers Sign Deal to Manufacture Generic of Molnupiravir

The EU has taken a major step towards reducing medicine shortages, by signing off on new legislation that will help to regulate the supply of drugs in Europe 

Learn more

27 Drug Makers Sign Deal to Manufacture Generic of Molnupiravir

27 Drug Makers Sign Deal to Manufacture Generic of Molnupiravir

27 Drug Makers Sign Deal to Manufacture Generic of Molnupiravir

27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low-and-middle-income countries (LMICs)

Learn more

What is a Drug Shortage

27 Drug Makers Sign Deal to Manufacture Generic of Molnupiravir

Rising costs of medicines in shortage

a qualitative study in the EU uncovered 20 different definitions for drug shortages with regulators each having varying definitions 

Learn more

Rising costs of medicines in shortage

Intellectual property rights of covid-19 vaccines

Rising costs of medicines in shortage

Drug shortages are today costing U.S. hospitals $359 million a year and wasting an additional 8.6 million hours of people's time 

Learn more

Supply chain process for medicines

Intellectual property rights of covid-19 vaccines

Intellectual property rights of covid-19 vaccines

 Did you know that the medicine you take every day likely has a complex supply chain process behind it? 

Learn more

Intellectual property rights of covid-19 vaccines

Intellectual property rights of covid-19 vaccines

Intellectual property rights of covid-19 vaccines

The global debate over whether or not to abolish intellectual property rights for covid-19 vaccines has brought a lot of different opinions

Learn more

This is life and death, and the public needs to know where their drugs come from and be assured they will always be available in a timely manner.


Stephen Schondelmeyer

Patient Impact

 

During times of drug shortages, it is patients who suffer.  Alternative drugs are used, modifications in treatments occur and costs increase. Between 2011 and 2014, the US Food and Drug Administration announced that there were 456 instances of drug shortages, ranging from sterile injectables, anti-infectivesand oncology treatments. Multiple factors contribute to drug shortages, including quality, manufacturing complexity, speed of regulation, decreased margins and inventory-related issues. Disease progression / worsening of symptoms.  


Patients are impacted with:- Risk of adverse events, greater toxicity, development of drug resistance, exposure to falsified medicines, suboptimal treatment or therapeutic failures and emotional distress for patients and their families.   


Every shortage is different in size, scope and significance

Medicine Shortages occur for many reasons, whether manufacturing, 

quality delays, or discontinuations, we can help mitigate the impact. 

Get in touch for a discussion to find out how we can help.

Contact us

Industry

Drug shortages stem from societal values. From the choices and expectations we have from pharmaceutical and biotechnology industries, the regulators and our health services. 

 

The drug shortage problem is getting worse –year on year data showing exponential increase. Attempts to solve the drug shortage problem continue to fail. COVID19 has made it worse.

Patient treatments are impacted with more lives being put at risk. Shortages are country specific reducing visibility for cross regional collaboration

Ethical

There is a moral and political imperative to respond to drug shortages as vigorously as possible in ethically and politically sophisticated ways. 

  

Adoption of new national regulations lacks European coordination and consequently reduces effectiveness of the measures, contributes to an inefficient allocation of stocks and causes shortages, both in Europe and globally

Economic

Generic drug market, where price competition is the primary way to gain market share, economic incentives are stacked firmly against investing in plant improvements or redundancies 

Safety

Institutions and governments may feel compelled to trade-off safety against access by,

  • allowing re-use of single-vials
  • allowing expired drugs to be used
  • allowing companies to use sub-standard & unapproved manufacturing processes
  • purchasing compounded or imported medicines that may be of poor quality or even counterfeit
  • expediting regulatory approval of new medicines

Market Overview

Powered by People, augmented by AI

The facts and figures

In the last 20 years, medicine shortages have become a growing worldwide issue, and the problem is only getting worse. These shortages have adverse economic, clinical and humanistic outcomes to both patients and the healthcare providers.  


In many developed countries, pharmaceutical products in shortage often become political problems.  Be

In the last 20 years, medicine shortages have become a growing worldwide issue, and the problem is only getting worse. These shortages have adverse economic, clinical and humanistic outcomes to both patients and the healthcare providers.  


In many developed countries, pharmaceutical products in shortage often become political problems.  Before the UK left the EU’s single market, many warned of the risk of medical supply shortages.  MEPs adopted a draft report on 12 October to strengthen the EU’s pharmaceutical strategy, so every patient has reliable and timely access to medicines as shortages have been increasing since 2000. 


MEPs called on the Commission, member states and EMA to develop: 

“an early warning system for drug shortages, based on a transparent and centralised European digital platform”. 

The facts and figures

Powered by People, augmented by AI

The facts and figures

EAHP 2019 Medicine Shortage Survey of hospital pharmacists; 

95% of Hospital Pharmacists consider shortages a current problem

Satisfaction with existing reporting systems was low (48%)


PGEU 2019 Medicine Shortage Survey - community pharmacists

In 67% of countries, over 200 medicines were listed as in short supply

Pharmacy staff spend 6,6 hours

EAHP 2019 Medicine Shortage Survey of hospital pharmacists; 

95% of Hospital Pharmacists consider shortages a current problem

Satisfaction with existing reporting systems was low (48%)


PGEU 2019 Medicine Shortage Survey - community pharmacists

In 67% of countries, over 200 medicines were listed as in short supply

Pharmacy staff spend 6,6 hours per week dealing with shortages

25% reported that there is no reporting system for shortages


PDA 2020 UK Pharmacists Survey 

Shortages affect 21% of prescription drugs

90% report shortages increased in last 12 months

Powered by People, augmented by AI

Powered by People, augmented by AI

Powered by People, augmented by AI

With a hard fought solution to the global shortage of medicine, addressing supply and demand gap for these scarce drugs. We're developing AI that finds what you need in time with real-time data on hand; creating an early warning system before looming drug shortages occur which will help mitigate their effects by connecting patients' needs

With a hard fought solution to the global shortage of medicine, addressing supply and demand gap for these scarce drugs. We're developing AI that finds what you need in time with real-time data on hand; creating an early warning system before looming drug shortages occur which will help mitigate their effects by connecting patients' needs as they arise with available medications. We analyze data in real time, extract insights and recommend what to do blending prescriptive and predictive analytics.


A new kind of customer service.  A peer to peer facilitation that improves access, lead times and patient outcomes.  Helping our customers to generate value through powerful insights. Unique operating system that sits above the fragmented network of existing on-demand activities. 


Making access more ethical than ever before. 

Thought leadership into Simplified Insights

Subscribe to our blog


Members of the Information Commissioner’s Office (ICO)  Registration No:  ZB231371 

Registered address:  Binley Business Park, Harry Weston Road, Binley, Coventry, England, CV3 2TX 

  • Blog
  • Privacy
  • Cookie
  • Accessibility Statement
  • AntiCorruption & Bribery
  • Diversity & Inclusion
  • Modern Slavery
  • Terms and Conditions

Copyright © 2021 iEthico - All Rights Reserved

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept